Approach significantly improved local control, and longer survival observed in trial ...

NeuExcell Therapeutics today announced that Dr. Yulun Huang will present the first-in-human clinical study of NXL-004 for ...

Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung ...

Summary: Implanting radioactive collagen tiles during brain surgery dramatically outperforms the current standard of care for patients with newly diagnosed brain metastases. The ROADS trial reveals ...

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...

A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that implanting collagen tiles during brain surgery to deliver targeted radiation therapy ...

The FDA has approved durvalumab (Imfinzi, AstraZeneca) in combination with Bacillus Calmette-Guerin (BCG) for adults with BCG-naive, high-risk non-muscle-invasive bladder cancer (NIMBC). Approval was ...

The U.S. FDA has approved Durvalumab in combination with bacillus Calmette-Guérin (BCG) for adults with BCG-naive, high-risk non–muscle-invasive bladder cancer (NMIBC). The approval was based ...

Intraoperative cesium-131 tile-based radiation therapy (TBRT) with GammaTile significantly improved local control, surgical bed recurrence-free survival (SB-RFS), and overall surv ...

Intradural spinal tumors constitute a significant proportion of central nervous system neoplasms. Surgical resection remains the definitive treatment modality to achieve adequate tumor control ...

CHICAGO, MAY 30, 2026 ― A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that ...

The FDA has approved an immunotherapy combination therapy for adult patients with Bacillus Calmette-Guérin-naive, high-risk ...